Search

everythinglearnresearchcommunity

for

Search:↓

Acne in reproductive-age women may be linked to conditions like PCOS and lifestyle factors, so doctors should check for these when treating acne.

Most women with polycystic ovary syndrome (PCOS) have menstrual issues, infertility, acne, and excessive body hair, with the most common type being the non-androgenic phenotype.

Women of reproductive age with polycystic ovary syndrome often experience hair loss.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

PCOS is common in young women, especially those aged 21-30, and often involves symptoms like irregular periods, weight gain, and acne.

Women with PCOS often experience skin issues like excess hair, acne, and hair loss.

More than half of the Thai women with PCOS had polycystic ovarian morphology.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Women aged 21-26 have a higher rate of PCOS.

HAIR-AN syndrome mainly affects obese women and can be improved with early diagnosis and treatment using insulin-sensitizing agents.

Nearly half of women with PCOS have metabolic syndrome, and lifestyle changes are crucial to prevent complications.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

Combining letrozole with metformin is the most effective treatment for inducing pregnancy in women with PCOS.

Hormonal dysfunctions, like PCOS, are common among reproductive-age women in India.

Micronutrient supplements significantly improved PCOS symptoms in women.

Low ferritin and vitamin D levels, past infections, stress, and weight changes can trigger hair loss in women.

The most common form of PCOS in the group was anovulatory PCOS, with no cases of obese PCOS, highlighting the importance of assessing lean women with menstrual issues.

High levels of Anti-Müllerian Hormone (AMH) in the blood can strongly predict Polycystic Ovarian Syndrome (PCOS) and related issues in women of reproductive age.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Obesity increases the risk of polycystic ovary syndrome and anemia in women who can have children.

COVID-19 vaccines are linked to menstrual changes in many women.

Oral and topical finasteride are effective and safe for treating female hair loss.

About 7% of Omani women visiting a gynecology clinic had polycystic ovarian syndrome, similar to rates in other countries.

Age is more important than BMI for IVF success in women with infertility and PCOS.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Menstrual cycles can be irregular for women of childbearing age.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

The treatment slightly increased hair growth and was safe for most women.